Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SUNCITY SYNTHETICS LTD.

NSE : NABSE : 530795ISIN CODE : INE584D01019Industry : Textile - Manmade FibresHouse : Private

BSE15.310.66 (+4.51 %)

PREV CLOSE ( ) 14.65

OPEN PRICE ( ) 15.38

BID PRICE (QTY) 14.65 (30)

OFFER PRICE (QTY) 15.32 (90)

VOLUME 3240

TODAY'S LOW / HIGH ( )14.65 15.38

52 WK LOW / HIGH ( ) 13.3348.86

NSE

This Company is not listed in NSE

Select year

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Operational & Financial Ratios

Earnings Per Share (Rs)

-1.14

0.26

-0.25

0.57

-7.84

CEPS(Rs)

-0.98

0.70

0.42

2.06

-4.71

DPS(Rs)

0.00

Book NAV/Share(Rs)

-0.98

0.17

-0.09

0.15

-0.41

Tax Rate(%)

4.57

-46.52

-120.55

-61.83

3.99

Margin Ratios

Core EBITDA Margin(%)

-33.19

2.09

3.65

11.72

-64.25

EBIT Margin(%)

-48.86

15.33

4.72

9.22

-68.36

Pre Tax Margin(%)

-50.58

4.38

-1.20

2.24

-86.00

PAT Margin (%)

-48.27

6.42

-2.64

3.62

-82.57

Cash Profit Margin (%)

-41.41

17.29

4.46

13.22

-49.59

Performance Ratios

ROA(%)

-15.86

2.45

-2.14

3.39

-27.30

ROE(%)

0.00

719.83

-806.72

0.00

-223.46

ROCE(%)

-26.64

6.50

4.43

9.90

-25.30

Asset Turnover(x)

0.33

0.38

0.81

0.94

0.33

Sales/Fixed Asset(x)

0.12

0.24

0.38

0.20

Working Capital/Sales(x)

-0.93

-19.45

-4.49

-8.82

-2.18

Efficiency Ratios

Fixed Capital/Sales(x)

8.35

8.31

4.12

2.61

4.97

Receivable days

132.46

62.43

17.09

19.54

30.02

Inventory Days

408.31

302.58

150.23

134.53

487.45

Payable days

74.09

68.42

53.69

40.90

Valuation Parameters

PER(x)

0.00

29.64

0.00

18.38

0.00

PCE(x)

-16.65

11.01

14.37

5.04

0.00

Price/Book(x)

-16.70

46.61

-64.62

67.41

0.00

Yield(%)

0.00

EV/Net Sales(x)

6.92

4.21

1.62

1.32

3.06

EV/Core EBITDA(x)

-21.49

41.28

13.70

11.06

-4.77

EV/EBIT(x)

-14.16

27.45

34.31

14.19

-4.46

EV/CE(x)

-18.54

1.78

1.60

1.61

1.40

M Cap / Sales

6.89

1.90

0.64

0.67

0.00

Growth Ratio

Net Sales Growth(%)

-41.56

-56.82

-39.29

63.18

-68.52

Core EBITDA Growth(%)

-284.61

-62.76

-39.99

130.39

-178.03

EBIT Growth(%)

-286.27

40.18

-69.27

122.17

-11.46

PAT Growth(%)

-539.22

205.13

-143.68

107.21

5.78

EPS Growth(%)

-539.26

205.14

-143.68

107.21

5.78

Financial Stability Ratios

Total Debt/Equity(x)

-0.10

56.83

-103.31

66.79

-46.22

Current Ratio(x)

0.49

0.96

0.65

0.76

0.65

Quick Ratio(x)

0.05

0.38

0.05

0.20

0.07

Interest Cover(x)

-28.42

1.40

0.80

1.32

-3.88

Total Debt/Mcap(x)

0.01

1.22

1.60

0.99